| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |